1. Home
  2. BEAM vs COLM Comparison

BEAM vs COLM Comparison

Compare BEAM & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

SELL

Current Price

$23.29

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

SELL

Current Price

$60.01

Market Cap

3.1B

ML Signal

SELL

Company Overview

Basic Information
Metric
BEAM
COLM
Founded
2017
1938
Country
United States
United States
Employees
N/A
9620
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
BEAM
COLM
Price
$23.29
$60.01
Analyst Decision
Strong Buy
Hold
Analyst Count
15
8
Target Price
$52.15
★ $69.83
AVG Volume (30 Days)
★ 1.7M
635.9K
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
★ 1.97%
EPS Growth
★ 82.31
N/A
EPS
N/A
★ 1.17
Revenue
$24,000.00
★ $3,042,478,000.00
Revenue This Year
N/A
$1.78
Revenue Next Year
$29.19
$3.12
P/E Ratio
★ N/A
$51.95
Revenue Growth
★ 33.33
N/A
52 Week Low
$20.23
$47.48
52 Week High
$38.26
$69.06

Technical Indicators

Market Signals
Indicator
BEAM
COLM
Relative Strength Index (RSI) 40.52 60.96
Support Level $22.49 $55.33
Resistance Level $26.72 $65.02
Average True Range (ATR) 1.17 1.45
MACD 0.01 0.37
Stochastic Oscillator 4.89 73.39

Price Performance

Historical Comparison
BEAM
COLM

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

Share on Social Networks: